Our success is built on diverse corporate management and financial industry experience.
Our directors have a combined wealth of leadership experience derived from extensive service guiding large, complex organizations as executive leaders or board members, and in government and academia. They collectively have substantive knowledge
and skills applicable to our business, including in the areas of regulation, public accounting and financial reporting, finance, risk management, business development, technology, marketing, operations, strategic planning, management development
and succession, compensation, corporate governance, public policy, international matters, banking and financial services.
Independent Chairman – Nominating and Governance Committee (Chair), Audit Committee
Lawrence A. Weinbach has served as independent chairman since January 2019. This follows his service as lead director from 2009 to 2018. He has been chairman of Great Western Products Holdings, LLC, a manufacturer and master distributor of food and nonfood concession products, since 2009 and a managing director of Yankee Hill Capital Management, LLC, a private equity firm, since 2006. Prior to that, he was the executive chairman of Unisys Corporation, a worldwide information services and technology company, from 2005 to 2006, and its chairman and chief executive officer from 1997 to 2004. He served as managing partner and chief executive of Andersen Worldwide, a global professional services organization, which included Arthur Andersen and the company now known as Accenture from 1989 to 1997.
Jeffrey S. Aronin
Director - Compensation and Leadership Development Committee
Jeffrey S. Aronin has been chairman and chief executive officer of Paragon Pharmaceutical Capital, LLC since 2010. He is also chairman and chief executive officer of Paragon Biosciences, LLC, a global healthcare development and biopharmaceutical
investment firm. From 2010 to 2017, Mr. Aronin was also chairman and chief executive officer of Marathon Pharmaceuticals, a research-based prescription biopharmaceutical company. From 2000 to 2009, he was president and chief executive
officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000. In 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc. Mr. Aronin served as president and chief executive officer of Lundbeck, Inc. during
its acquisition and integration of Ovation Pharmaceuticals.
Mary K. Bush
Director - Nominating and Governance Committee, Risk Oversight Committee
Mary K. Bush has served as the chairman of Bush International, LLC, a financial and business strategy advisory firm, since 1991. She has served as managing director of the Federal Housing Finance Board, where she established financial
policies and oversaw management and safety and soundness for 12 Federal Home Loan Banks. She served as vice president and head of International Finance of Fannie Mae and as the U.S. Alternate Executive Director of the International Monetary
Fund Board. In 2007, she served on the U.S. Department of the Treasury's Advisory Commission on the Auditing Profession. Ms. Bush is a member of the board of directors of ManTech International Corporation, Marriott International, Inc., T. Rowe Price Group, Inc., and Bloom Energy. In the past five years, she has also served as a director of the Pioneer Family of Mutual Funds.
Gregory C. Case
Director - Compensation and Leadership Development Committee (Chair)
Gregory C. Case has been president and chief executive officer of Aon plc, a leading global provider of risk management, insurance and reinsurance brokerage, since 2005 and is a member of Aon's board of directors. Prior to joining Aon,
Mr. Case was with McKinsey & Company, an international management consulting firm, for 17 years, most recently serving as head of the Financial Services Practice. Prior to joining McKinsey, he worked for the investment banking firm of
Piper, Jaffray and Hopwood and the Federal Reserve Bank in Kansas City.
Candace H. Duncan
Director - Audit Committee, Nominating and Governance Committee
Ms. Duncan retired from KPMG LLP, a global network of professional firms providing audit, tax and advisory services, in November 2013 where she was managing partner of the Washington, D.C. metropolitan area since 2009. Ms. Duncan also
was on the KPMG LLP board of directors from 2009 to 2013, and served as chair of the board's nominating committee as well as the partnership and employer of choice committee. Prior to that, she served in various roles at the firm, including
managing partner for audit for the Midatlantic area and audit partner in charge for the Virginia business unit. Ms. Duncan was admitted to the KPMG LLP partnership in 1987 and had more than 35 years of experience as a professional with
the firm. Ms. Duncan is a member of the board of directors of FTD Companies, Inc. and Teleflex Inc.
Joseph F. Eazor
Director - Audit Committee
Joseph F. Eazor was named chief executive officer of Rackspace, a leading managed cloud company, in June 2017. He previously served as the president and chief executive officer of EarthLink, Inc., a leading communications and IT services
provider, and was a member of EarthLink's board from January 2014 until February 2017. From 2011 to 2013, Mr. Eazor served as executive vice president and chief operating officer of global sales and customer operations at EMC. Prior
to EMC, he served in a variety of leadership roles at Hewlett Packard and Electronic Data Systems. Mr. Eazor serves on the board of Commvault, a data protection and information management company.
Cynthia A. Glassman
Director - Audit Committee (Chair)
Dr. Cynthia A. Glassman was appointed by President Bush as Under Secretary for Economic Affairs at the U.S. Department of Commerce from 2006 to 2009 and as Commissioner of the U.S. Securities and Exchange Commission from 2002 to 2006,
including serving as acting chair during the summer of 2005. She is a director of Navigant Consulting, Inc. and a Senior Research Scholar at the Institute for Corporate Responsibility at the George Washington University School of Business.
Roger C. Hochschild
Roger C. Hochschild, chief executive officer and president of Discover, was elected to the board in August 2018. Mr. Hochschild was president and chief operating officer of Discover from 2004 to 2018. He was executive vice president, chief administrative and strategic officer for Morgan Stanley from 2001 to 2004, and was executive vice president, chief marketing officer - Discover from 1998 to 2001, when Discover was a part of Morgan Stanley. Mr. Hochschild is also on the board of directors of Principal Financial Group.
Thomas G. Maheras
Director - Risk Oversight Committee
Thomas G. Maheras is the managing partner of Tegean Capital Management, LLC, an investment advisory firm since 2008. Prior to that he was chairman and co-chief executive officer of Citi Markets and Banking, the investment banking division
of Citigroup, Inc. He has served as chairman of the U.S. Treasury Department Borrowing Advisory Committee and as an executive committee member of the Board of Directors of the Securities Industry and Financial Markets Association.
Michael H. Moskow
Director - Risk Oversight Committee (Chair)
Michael H. Moskow retired as president and chief executive officer of the Federal Reserve Bank of Chicago in 2007, where he had served since 1994. He is currently Vice Chair and Distinguished Fellow, Global Economy at The Chicago Council
on Global Affairs. From 1993 to 1994, he was a full-time faculty member at Northwestern University's Kellogg School of Management. Prior to teaching at Northwestern, Mr. Moskow was a Deputy U.S. Trade Representative, following his appointment
by President Bush in 1991. From 1969 to 1977, he held a number of senior positions with the U.S. government, including undersecretary of labor at the U.S. Department of Labor, director of the Council on Wage and Price Stability and senior
staff economist with the Council of Economic Advisers. Mr. Moskow serves on the board of directors of Education Corporation of America and Commonwealth Edison Company, a subsidiary of Exelon Corporation.
Mark A. Thierer
Director - Compensation and Leadership Development Committee
Mark A. Thierer is managing partner of AssetBlue Investment Group. He was chief executive officer of OptumRx, a pharmacy care services company, until September 2017. He previously served as chairman and chief executive officer of Catamaran
Corporation, one of the nation's largest pharmacy benefit management companies, which combined with OptumRx in 2015. Mr. Thierer was a member of Catamaran's board of directors and from 2008-2011, he was president and chief executive
officer of Catamaran. From 2006-2008, he served as its president and chief operating officer.